言語 |
英語
|
著者 |
Li Yuanyuan
Life Science Research Institute, Saga Medical Center Koseikan, Saga, Japan / Division of Biochemistry and Innovative Cancer Therapy, Chiba Cancer Center Research Institute, Chiba, Japan
Ohira Miki
Division of Cancer Genomics, Chiba Cancer Center Research Institute, Chiba, Japan / Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan
Zhou Yong
BGI-Shenzhen, Shenzhen, China
Xiong Teng
BGI-Shenzhen, Shenzhen, China
Luo Wen
BGI-Shenzhen, Shenzhen, China
Yang Chao
BGI-Shenzhen, Shenzhen, China
Li Xiangchun
BGI-Shenzhen, Shenzhen, China
Gao Zhibo
BGI-Shenzhen, Shenzhen, China
Zhou Rui
BGI-Shenzhen, Shenzhen, China
Nakamura Yohko
Division of Biochemistry and Innovative Cancer Therapy, Chiba Cancer Center Research Institute, Chiba, Japan
Kamijo Takehiko
Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan
Kaneko Yasuhiko
Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan
Ueyama Junichi
Division of Pediatrics and Perinatology, Tottori University School of Medicine, Tottori, Japan
Tajiri Tatsuro
Department of Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan
Zhang Hongyan
BGI-Shenzhen, Shenzhen, China
Wang Jian
BGI-Shenzhen, Shenzhen, China / James D. Watson Institute of Genome Science, Hangzhou, China
Yang Huanming
BGI-Shenzhen, Shenzhen, China / James D. Watson Institute of Genome Science, Hangzhou, China
Yin Ye
BGI-Shenzhen, Shenzhen, China
Nakagawara Akira
Life Science Research Institute, Saga Medical Center Koseikan, Saga, Japan / Division of Biochemistry and Innovative Cancer Therapy, Chiba Cancer Center Research Institute, Chiba, Japan
|
主題 | whole-exome sequencing; array CGH; neuroblastoma; familial neuroblastoma; genomic diversity
|
掲載誌名 |
ONCOTARGET
|
巻 | 8
|
号 | 34
|
開始ページ | 56684
|
終了ページ | 56697
|
ISSN(Online) | 1949-2553
|
発行日 | 2017-08-22
|
DOI | |
PubMed ID | |
出版者 | IMPACT JOURNALS LLC
|
資料タイプ |
学術雑誌論文
|
部局 |
医学部
|
備考 | This work was supported in part by a Grant from Takeda Science Foundation (AN, MO), the National Cancer Center Research and Development Fund (AN), Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT) (AN, MO, YN), the Research Program on Pediatric Solid Tumors from the Japan Agency for Medical Research and Development (AN) and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (JSPS KAKENHI Grant Number: 24249061 (AN), 23591562 (MO) and 26461603 (MO)).
|